Henry Sallembien
Member of Hg's New York Team


Henry is based in our New York office and focuses on software and services investments in North America. Since joining Hg, Henry has worked on Hg’s investments in Gen II, and Prophix.

Henry joined Hg in 2019 from the direct private equity team at CDPQ, where he worked on upper mid-market and large cap transactions in technology, healthcare, and business services. During his time at CDPQ, he was involved in the firm’s investments in AlliedUniversal and Biogroup. Prior to this, Henry worked at Fisher Lynch Capital, where he focused on direct equity co-investments. He started his career at Outcome Capital, a boutique M&A firm specialized in technology and healthcare.

Henry holds a Bachelor of Science from the McIntire School of Commerce at the University of Virginia, and is fluent in French.